Michael McClellan

Michael McClellan is currently the Principal CMC Scientist at Kymanox, where they conduct EU/FDA regulatory risk assessments and support NDA submissions. Previously, they worked as a Scientist at Novan, Inc., focusing on analytical method development, and as an Analytical Scientist at Tergus Pharma, where they handled method validation and quality testing. Earlier in their career, they served as a Quality Analyst at Mallinckrodt Pharmaceuticals, performing testing on manufactured products and raw materials. Michael holds a Bachelor's degree in Chemistry and Physics from the University of North Carolina Wilmington and a Master's degree in Medicinal and Pharmaceutical Chemistry from the University of Florida.